7 drug(s) with this reaction
4,048 total reports
Sepsis has been reported as an adverse reaction across 7 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,048 adverse event reports mention sepsis in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with sepsis, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have sepsis listed in their FDA adverse event reports, sorted by report count:
In addition to sepsis, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
7 drug(s) manufactured by Abbvie Inc have sepsis listed in their FDA adverse event reports: VENETOCLAX, UPADACITINIB, FENOFIBRATE, PARICALCITOL, RISANKIZUMAB-RZAA, and others.
There are a combined 4,048 reports of sepsis across 7 Abbvie Inc drug(s) in the FDA adverse event database.